Zimbabwe has declined a substantial US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years due to the United States' insistence on confidential biological samples.
The decision came to light following a government memo dated December was disclosed, which showed President Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman later explained that the United States was seeking health data for research and commercial gain but refused to share the benefits from any future treatments.
"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged continued talks to find a deal suitable to both sides so the country's vital HIV treatment initiative can proceed.
Wider Implications
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court blocked a related deal with the US following concerns were raised about the security of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government deals to enhance openness and accountability.
According to statements, Sixteen African countries have so far signed similar agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to share its biological resources and data over an extended period, with no corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Put simply, our country would supply the raw materials for scientific discovery without any certainty that the final treatments would be accessible to our people if a future pandemic arise."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting frameworks previously established via the global organization.
Mangwana cited its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.
"This mechanism is intended to ensure that when a nation provides its data, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
These objections over the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to ongoing dialogue with our American counterparts on how subsequent collaboration might be designed in a manner that respects the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but urged that negotiations should continue since a large portion of the country's Aids initiatives were funded by international support.
"In cases where specific concerns arise, including those relating to information security or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," it added.
The situation emphasises the continuing tensions between accepting much-needed international aid and safeguarding local interests in an increasingly interconnected world.